Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ANGO

Angiodynamic Inc

Dec 26 • 04:00PM ET

9.01

Dollar change +0.32
Percentage change 3.68	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: JNJ SYK MDT BSX EW ABT BAX ZBH HOLX XRAY

| Held by: IWM VTI VXF IWN DFAT SCHA VTWO DFAS VHT PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.04	Insider Own	4.76%	Shs Outstand	41.00M	Perf Week	0.90%
Market Cap	366.11M	Forward P/E	-	EPS next Y	-0.22	Insider Trans	1.20%	Shs Float	38.70M	Perf Month	28.90%
Income	-243.03M	PEG	-	EPS next Q	-0.11	Inst Own	79.28%	Short Float	2.59%	Perf Quarter	19.97%
Sales	292.73M	P/S	1.25	EPS this Y	-5.26%	Inst Trans	-0.71%	Short Ratio	1.71	Perf Half Y	51.94%
Book/sh	4.79	P/B	1.88	EPS next Y	45.00%	ROA	-61.72%	Short Interest	1.00M	Perf Year	13.05%
Cash/sh	1.35	P/C	6.66	EPS next 5Y	15.00%	ROE	-77.85%	52W Range	5.26 - 9.58	Perf YTD	14.92%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-121.47%	52W High	-5.95%	Beta	0.66
Dividend TTM	-	Quick Ratio	1.41	Sales past 5Y	2.66%	Gross Margin	47.61%	52W Low	71.29%	ATR (14)	0.43
Dividend Ex-Date	-	Current Ratio	2.25	EPS Y/Y TTM	-4001.62%	Oper. Margin	-11.21%	RSI (14)	64.08	Volatility	5.03% 5.24%
Employees	748	Debt/Eq	0.03	Sales Y/Y TTM	-12.85%	Profit Margin	-83.02%	Recom	1.00	Target Price	13.00
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	-127.42%	Payout	-	Rel Volume	0.61	Prev Close	8.69
Sales Surprise	-0.65%	EPS Surprise	25.02%	Sales Q/Q	-14.22%	Earnings	Jan 08 BMO	Avg Volume	587.41K	Price	9.01
SMA20	8.69%	SMA50	21.00%	SMA200	32.47%	Trades		Volume	358,829	Change	3.68%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-05-24	Upgrade	Oppenheimer	Perform → Outperform	$12
Sep-25-23	Initiated	H.C. Wainwright	Buy	$19
Apr-17-23	Downgrade	Raymond James	Strong Buy → Outperform	$14 → $13
Oct-15-21	Upgrade	Canaccord Genuity	Hold → Buy	$28 → $37
Aug-20-21	Initiated	Oppenheimer	Perform
Nov-25-20	Upgrade	Raymond James	Mkt Perform → Strong Buy	$18
Apr-08-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-01-19	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Apr-03-18	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-05-18	Downgrade	Craig Hallum	Buy → Hold
Apr-07-17	Reiterated	Cantor Fitzgerald	Overweight	$20 → $21
Mar-30-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight
Feb-08-17	Initiated	Barclays	Equal Weight	$17
Nov-04-16	Initiated	Cantor Fitzgerald	Buy
Apr-08-16	Resumed	Piper Jaffray	Neutral
Jan-08-16	Reiterated	Canaccord Genuity	Buy	$17.50 → $14.50
Nov-10-15	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-24-15	Initiated	KeyBanc Capital Mkts	Overweight
Jun-19-14	Upgrade	Canaccord Genuity	Hold → Buy	$16.25 → $20
Oct-09-12	Reiterated	Canaccord Genuity	Hold	$14 → $13.50

Show Previous Ratings

Dec-19-24 05:00PM	AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event (Business Wire)
Dec-10-24 09:29AM	Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength? (Zacks)
Dec-09-24 01:03PM	NanoKnife gains FDA clearance for prostate tissue ablation (Medical Device Network) +23.29%
06:00AM	AngioDynamics Receives FDA Clearance for The NanoKnife System for Prostate Tissue Ablation (Business Wire)
Nov-01-24 09:55AM	Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Here's is How to Trade (Zacks)
08:08AM	Loading…
Oct-24-24 08:08AM	AngioDynamics launches long-term study of NanoKnife for prostate cancer (Clinical Trials Arena)
Oct-23-24 08:00AM	AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife System (Business Wire)
Oct-22-24 10:36AM	AngioDynamics NanoKnife System gains CPT codes for prostate and liver treatments (Medical Device Network) +11.16%
Oct-21-24 08:00AM	AngioDynamics Announces American Medical Associations CPT Editorial Panel Grants Category I CPT for Irreversible Electroporation (IRE) in Prostate and Liver (Business Wire)
Oct-08-24 09:35AM	AngioDynamics (ANGO) Loses -15.86% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Oct-04-24 07:58AM	AngioDynamics Sees Growth Amidst Challenges in Fiscal 2025 (TipRanks)
03:24AM	Q1 2025 AngioDynamics Inc Earnings Call (Thomson Reuters StreetEvents)
03:00AM	AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highlights: A Promising Start with ... (GuruFocus.com)
Oct-03-24 11:23AM	Why AngioDynamics Stock Is Crashing Today (Motley Fool) -16.73%
07:40AM	AngioDynamics (ANGO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
06:37AM	Loading…
06:37AM	AngioDynamics: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results (Business Wire)
Oct-02-24 09:00AM	AngioDynamics Inc (ANGO) Q1 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Sep-20-24 06:33AM	AngioDynamics initiates thrombectomy system trial across Europe (Medical Device Network)
Sep-19-24 04:40PM	AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18 System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes (Business Wire)
08:00AM	AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024 (Business Wire)
Sep-04-24 06:33AM	AngioDynamics wins EU CE mark for Auryon system to treat PAD (Medical Device Network)
Sep-03-24 08:30AM	AngioDynamics Announces CE Mark Approval in Europe for the Auryon System (Business Wire)
Sep-01-24 08:32AM	TipRanks Perfect 10 List: 2 Top-Scoring Stocks Worth Watching (TipRanks)
Aug-27-24 12:00PM	AngioDynamics (ANGO) Upgraded to Strong Buy: Here's Why (Zacks)
Aug-15-24 11:30AM	AngioDynamics (ANGO) Down 3.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Aug-14-24 09:55AM	Does AngioDynamics (ANGO) Have the Potential to Rally 77.03% as Wall Street Analysts Expect? (Zacks)
Aug-01-24 09:55AM	Should You Buy AngioDynamics (ANGO) After Golden Cross? (Zacks)
Jul-29-24 04:15PM	AngioDynamics to Participate in Upcoming Investor Conferences (Business Wire)
09:55AM	Wall Street Analysts Predict a 74.25% Upside in AngioDynamics (ANGO): Here's What You Should Know (Zacks)
12:29PM	Loading…
Jul-17-24 12:29PM	AngioDynamics (ANGO) Q4 Earnings Top Estimates, Gross Margin Down (Zacks)
03:24AM	Q4 2024 AngioDynamics Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-16-24 10:52AM	ANGO Stock Earnings: AngioDynamics Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace) +26.64%
07:40AM	AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:48AM	AngioDynamics: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results (Business Wire)
Jul-08-24 04:30PM	AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024 (Business Wire)
Jun-13-24 08:23AM	First patient implanted with Philips Duo Venous stent system (Medical Device Network)
May-22-24 12:18PM	AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval (Zacks) +7.85%
May-21-24 05:30PM	AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18 System (Business Wire)
May-06-24 04:45PM	AngioDynamics' APEX-AV Trial Results Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions (Business Wire)
May-02-24 12:34AM	Oppenheimer Predicts Over 100% Rally for These 2 Healthcare Stocks (TipRanks) +5.01%
Apr-08-24 09:26AM	AngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call Transcript (Insider Monkey) -5.97%
Apr-05-24 11:52AM	AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates (Zacks) +9.84%
11:43AM	AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment (Zacks)
Apr-04-24 10:13PM	Q3 2024 AngioDynamics Inc Earnings Call (Thomson Reuters StreetEvents) +5.26%
02:53PM	Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock Soars (Benzinga)
11:53AM	ANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024 (InvestorPlace)
08:51AM	AngioDynamics Inc (ANGO) Posts Q3 Fiscal 2024 Results: A Mixed Performance Amidst Asset Divestiture (GuruFocus.com)
07:11AM	AngioDynamics: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture (Business Wire)
06:45AM	AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE (Business Wire)
Apr-02-24 10:32AM	AngioDynamics (ANGO) Settles Patent Litigations With BD (Zacks) +6.17%
Apr-01-24 05:26PM	AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc. (Business Wire)
Mar-28-24 10:00AM	Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Mar-19-24 04:01PM	AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024 (Business Wire)
Mar-15-24 06:15PM	AngioDynamics (ANGO) Declines More Than Market: Some Information for Investors (Zacks)
Mar-08-24 06:15PM	Why AngioDynamics (ANGO) Dipped More Than Broader Market Today (Zacks)
Mar-06-24 04:01PM	AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference (Business Wire)
Mar-01-24 06:15PM	AngioDynamics (ANGO) Gains But Lags Market: What You Should Know (Zacks)
Feb-22-24 06:15PM	Here's Why AngioDynamics (ANGO) Gained But Lagged the Market Today (Zacks)
Feb-16-24 10:57AM	AngioDynamics (ANGO) Divests Its PICC & Midline Businesses (Zacks)
Feb-15-24 06:15PM	Why AngioDynamics (ANGO) Outpaced the Stock Market Today (Zacks)
04:05PM	AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million (Business Wire)
Feb-09-24 06:15PM	AngioDynamics (ANGO) Stock Sinks As Market Gains: Here's Why (Zacks)
Jan-25-24 10:35AM	AngioDynamics' (ANGO) New XL Catheter to Help in PAD Treatment (Zacks)
Jan-23-24 08:00AM	AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease (Business Wire)
Jan-08-24 10:17AM	AngioDynamics (ANGO) Q2 Earnings Top Estimates, Revenues Miss (Zacks)
08:29AM	AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2024 Earnings Call Transcript (Insider Monkey)
Jan-06-24 12:25AM	Q2 2024 AngioDynamics Inc Earnings Call (Thomson Reuters StreetEvents)
Jan-05-24 03:35PM	Why AngioDynamics Stock Got Destroyed Today (Motley Fool) -19.87%
02:13PM	AngioDynamics Inc (ANGO) Reports Fiscal 2024 Second Quarter Results and Revises Full-Year Guidance (GuruFocus.com)
12:51PM	ANGO Stock Earnings: AngioDynamics Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
12:20PM	Greenbrier, Constellation Brands rise; AngioDynamics, Agilon Health fall, Friday, 1/5/2024 (Associated Press Finance)
08:10AM	AngioDynamics (ANGO) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:24AM	AngioDynamics Q2 Results Miss Estimates; Boosts FY24 Adj. EPS Outlook (RTT News)
07:09AM	AngioDynamics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance (Business Wire)
Dec-29-23 10:00AM	Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Dec-21-23 04:01PM	AngioDynamics to Present at the J.P. Morgan Healthcare Conference (Business Wire)
Dec-19-23 06:15PM	Why AngioDynamics (ANGO) Outpaced the Stock Market Today (Zacks)
Dec-11-23 06:15PM	AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Dec-07-23 04:01PM	AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024 (Business Wire)
08:00AM	AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism (Business Wire)
Dec-04-23 06:15PM	AngioDynamics (ANGO) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Nov-28-23 06:15PM	AngioDynamics (ANGO) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Nov-22-23 06:15PM	AngioDynamics (ANGO) Outperforms Broader Market: What You Need to Know (Zacks)
Nov-16-23 06:15PM	AngioDynamics (ANGO) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Nov-10-23 06:15PM	AngioDynamics (ANGO) Advances But Underperforms Market: Key Facts (Zacks)
Oct-06-23 09:00AM	Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
Oct-05-23 10:45AM	AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates (Zacks)
08:18AM	AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2024 Earnings Call Transcript (Insider Monkey)
Oct-04-23 11:51PM	Q1 2024 AngioDynamics Inc Earnings Call (Thomson Reuters StreetEvents)
06:15PM	Why Angiodynamics Stock Sank Today (Motley Fool)
12:24PM	AngioDynamics Inc (ANGO) Reports Strong Q1 2024 Performance, Reaffirms Fiscal Year 2024 Guidance (GuruFocus.com)
08:15AM	AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:13AM	AngioDynamics: Fiscal Q1 Earnings Snapshot (AP Finance)
07:00AM	AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance (Business Wire)
Sep-27-23 10:00AM	Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Sep-25-23 01:21PM	Why AngioDynamics Stock Popped on Monday (Motley Fool)

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nighan Warren JR	SVP Quality and Regulatory	Oct 07 '24	Buy	6.09	768	4,677	45,777	Oct 10 03:22 PM
Nighan Warren JR	SVP Quality and Regulatory	Oct 10 '24	Buy	6.08	100	608	45,877	Oct 10 03:22 PM
Trowbridge Stephen A	EVP and CFO	Oct 08 '24	Buy	5.86	1,700	9,962	172,711	Oct 08 06:27 PM
Clemmer James C	President and CEO	Oct 07 '24	Buy	6.03	20,000	120,600	681,582	Oct 08 04:32 PM
Piccinini Laura	SVP International	Jul 17 '24	Option Exercise	0.00	4,439	0	42,491	Aug 02 09:55 PM
Clemmer James C	President and CEO	Jul 17 '24	Option Exercise	0.00	56,279	0	690,312	Aug 02 09:53 PM
Nighan Warren JR	SVP Quality and Regulatory	Jul 17 '24	Option Exercise	0.00	5,677	0	46,675	Aug 02 09:50 PM
Campbell Chad Thomas	SVP/GM, Vascular Access	Jul 17 '24	Option Exercise	0.00	6,600	0	70,187	Aug 02 09:48 PM
Trowbridge Stephen A	EVP and CFO	Jul 17 '24	Option Exercise	0.00	11,142	0	177,612	Aug 02 09:48 PM
Clemmer James C	President and CEO	Apr 08 '24	Buy	6.70	10,000	67,000	539,066	Apr 08 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ANGO

Angiodynamic Inc

Upgrade your FINVIZ experience